vidence-based Practice Graphic
rritable Bowel Syndrome Graphic
Where you are...

Guideline Resource Info & Algorithm
...................................


IBS Guideline Resource Kit
 Introduction
 Guideline Resource Info & Algorithm
 Info for Patients & Clinicians
 The Science
Implementation Tips
 Impact Assessment
Delfini Evidence & Usability Scale
(Use BACK to return from the scale)
Website Map

Downloads
Introduction [PDF]
2012 Update (not incorporated) [PDF]
Guideline Resource Information & Algorithm [PDF]
 Information for Patients & Clinicians [PDF]
The Science: Treatment [PDF]
The Science: Diagnosis [PDF]
The Science: Communications [PDF]
Implementation Tips [PDF]
Impact Assessment Template [Excel]

...................................
Return to Delfini Main Menu

Delfini SERVICES
We offer a wide range of supportive services with the ultimate goal of increasing health care organizations’ and clinicians’ abilities to provide high quality, evidence-based care and to improve medical decision-making for organizations, leaders, teams, clinicians and patients.
Delfini About Our Work Delfini Group EBM DolphinDelfini Group EBM Dolphin
Resources at —

 

 


“EXPLICIT" EVIDENCE-BASED CLINICAL PRACTICE GUIDELINE RESOURCE KIT
Irritable Bowel Syndrome (IBS)

March 2003; FDA Addendum 4/04; Herbal Preparations 07/06; ROME III Diagnostic Criteria 06/09; 01/2012: Update—Not incorporated, only available as separate document—see Downloads

NOTE: 01/2012: Update—Not incorporated, only available as separate document—see Downloads

THE SCIENCE

NOTE 01/2012: Update—Not incorporated, only available as separate document—see Downloads


References
Systematic Reviews
Delfini Evidence & Usability Scale — (Use BACK to return from the scale)
Evidence-based Medicine (EBM) for consumers —
     Using Scientific Information in Medicine — About the principles and processes we used to analyze this information

References

1. Evidence-based position statement on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002 Nov;97(11 Suppl):S1-5).

2. Brandt LJ, Bjorkman D, Fennerty MB et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002 Nov;97(11 Suppl):S7-26).

3. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J. 1978 Sep 2;2(6138):653-4.

4. Thompson WG, Irvine EJ, Pare P et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci. 2002 Jan;47(1):225-35.

5. Olden KW. Diagnosis of irritable bowel syndrome. Gastroenterology 2002 May;122(6):1701-14.

6. Vanner SJ, Depew WT, Paterson WG, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome.Am J Gastroenterol. 1999 Oct;94(10):2912-7.

7. Chey WD, Olden K, Carter E et al. Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women. Am J Gastroenterol 2002 Nov;97(11):2803-11.

8. Stewart MA. Effective Physician-Patient Communication and Health Outcomes: A Review CMAJ 1995.152:1423-1433.

9. Hall JA; Roter DL; Katz NR. Meta-analysis of correlates of provider behavior in medical encounters. Medical Care;1988, 26:657-675.

10. Beck RS, Daughtridge R, Sloane PD. Physician-Patient Communication in the Primary Care Office: A Systematic Review. JABFP 2002. 15:25-38. The Journal of the American Board of Family Practice

11. Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol. 2002 Nov;97(11):2812-9.

12. Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult coeliac disease with irritable bowel syndrome: A case-control study in patients fulfilling the ROME II criteria referred to secondary care. Lancet 2001;358:1504-8.

13. Camilleri, M, Chey, WY, Mayer, EA, et al. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med 2001; 161:1733.

14. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997 Jun;112(6):2120-37.

15. Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology. 1987 May;92(5 Pt 1):1282-4.

16. Friedman, G. Diet and the irritable bowel syndrome. Gastroenterol Clin North Am 1991; 20:313.

17. Kaplan MA, Prior MJ, Ash RR et al. Loperamide-simethicone vs loperamide alone, simethicone alone, and placebo in the treatment of acute diarrhea with gas-related abdominal discomfort. A randomized controlled trial. Arch Fam Med 1999 May-Jun;8(3):243-8.

18. Lustman F, Walters EG, Shroff NE, et al. Diphenoxylate hydrochloride (Lomotil) in the treatment of acute diarrhoea. Br J Clin Pract. 1987 Mar;41(3):648-51.

19. Harford WV, Krejs GJ, Santa Ana CA et al. Acute effect of diphenoxylate with atropine (Lomotil) in patients with chronic diarrhea and fecal incontinence. Gastroenterology. 1980 Mar;78(3):440-3.

20. Talley NJ, Phillips SF, Mulvihill C et al. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut 1990 Jan:31 (1):77-81.

21. Gatto NM, Frucht H, Sundararajan V, et al. Risk of Perforation After Colonoscopy and Sigmoidoscopy: A Population-based Study. J Natl Cancer Inst 2003; 95:230-6.

22. Madisch A, Holtmann G, Plein K, Hotz J. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial. Aliment Pharmacol Ther 2004; 19: 271–279.

23. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006 Apr;130(5):1480-91.PMID: 16678561

Systematic Reviews

Reference PDF
Treatment
 2. Brandt LJ, Bjorkman D, Fennerty MB et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol. 2002 Nov;97(11 Suppl):S7-26). Brandt
Diagnosis
 11. Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol. 2002 Nov;97(11):2812-9. Cash
Communications
 10. Beck RS, Daughtridge R, Sloane PD. Physician-Patient Communication in the Primary Care Office: A Systematic Review. JABFP 2002. 15:25-38. The Journal of the American Board of Family Practice. Beck



Return IBS Introduction Page
Return Delfini Home Page

© 2002-2012 Delfini Group, LLC. All Rights Reserved Worldwide.
Dolphin photo for Dolphins Poolside attributed to RevolverOcelo. Delfini Boat thanks to Dr. Bat Shunatona.
Thanks too to contributors to Openclipart.org and Wiki Media.

Use of this website implies your agreement to our Notices.

Help for Clinicians and Patients: Irritable Bowel Syndrome